Carlsson J - Search Results

1

[(111)In]Bz-DTPA-hEGF: Preparation and in vitro characterization of a potential anti-glioblastoma targeting agent.

Sundberg AL, Orlova A, Bruskin A, Gedda L, Carlsson J, Blomquist E, Lundqvist H, Tolmachev V. Sundberg AL, et al. Among authors: carlsson j. Cancer Biother Radiopharm. 2003 Aug;18(4):643-54. doi: 10.1089/108497803322287736. Cancer Biother Radiopharm. 2003. PMID: 14503960

2

Treatment of cultured glioma cells with the EGFR-TKI gefitinib ("Iressa", ZD1839) increases the uptake of astatinated EGF despite the absence of gefitinib-mediated growth inhibition.

Sundberg AL, Almqvist Y, Tolmachev V, Carlsson J. Sundberg AL, et al. Among authors: carlsson j. Eur J Nucl Med Mol Imaging. 2003 May;30(5):727-9. doi: 10.1007/s00259-003-1129-x. Epub 2003 Mar 7. Eur J Nucl Med Mol Imaging. 2003. PMID: 12740721

3

Cellular retention of radioactivity and increased radiation dose. Model experiments with EGF-dextran.

Sundberg AL, Blomquist E, Carlsson J, Steffen AC, Gedda L. Sundberg AL, et al. Among authors: carlsson j. Nucl Med Biol. 2003 Apr;30(3):303-15. doi: 10.1016/s0969-8051(02)00421-3. Nucl Med Biol. 2003. PMID: 12745022

4

Combined effect of gefitinib ('Iressa', ZD1839) and targeted radiotherapy with 211At-EGF.

Sundberg AL, Almqvist Y, Orlova A, Blomquist E, Jensen HJ, Gedda L, Tolmachev V, Carlsson J. Sundberg AL, et al. Among authors: carlsson j. Eur J Nucl Med Mol Imaging. 2003 Oct;30(10):1348-56. doi: 10.1007/s00259-003-1308-9. Epub 2003 Aug 21. Eur J Nucl Med Mol Imaging. 2003. PMID: 12937952

5

[177Lu]Bz-DTPA-EGF: Preclinical characterization of a potential radionuclide targeting agent against glioma.

Sundberg AL, Gedda L, Orlova A, Bruskin A, Blomquist E, Carlsson J, Tolmachev V. Sundberg AL, et al. Among authors: carlsson j. Cancer Biother Radiopharm. 2004 Apr;19(2):195-204. doi: 10.1089/108497804323071977. Cancer Biother Radiopharm. 2004. PMID: 15186600

6

Comparative biodistribution of potential anti-glioblastoma conjugates [111In]DTPA-hEGF and [111In]Bz-DTPA-hEGF in normal mice.

Tolmachev V, Orlova A, Wei Q, Bruskin A, Carlsson J, Gedda L. Tolmachev V, et al. Among authors: carlsson j. Cancer Biother Radiopharm. 2004 Aug;19(4):491-501. doi: 10.1089/cbr.2004.19.491. Cancer Biother Radiopharm. 2004. PMID: 15453964

7

Targeting against epidermal growth factor receptors. Cellular processing of astatinated EGF after binding to cultured carcinoma cells.

Orlova A, Sjöstrom A, Lebeda O, Lundqvist H, Carlsson J, Tolmachev V. Orlova A, et al. Among authors: carlsson j. Anticancer Res. 2004 Nov-Dec;24(6):4035-41. Anticancer Res. 2004. PMID: 15736449 Free article.

8

In vitro characterization of a bivalent anti-HER-2 affibody with potential for radionuclide-based diagnostics.

Steffen AC, Wikman M, Tolmachev V, Adams GP, Nilsson FY, Ståhl S, Carlsson J. Steffen AC, et al. Among authors: carlsson j. Cancer Biother Radiopharm. 2005 Jun;20(3):239-48. doi: 10.1089/cbr.2005.20.239. Cancer Biother Radiopharm. 2005. PMID: 15989469

9

Preparation and evaluation of (68)Ga-DOTA-hEGF for visualization of EGFR expression in malignant tumors.

Velikyan I, Sundberg AL, Lindhe O, Höglund AU, Eriksson O, Werner E, Carlsson J, Bergström M, Långström B, Tolmachev V. Velikyan I, et al. Among authors: carlsson j. J Nucl Med. 2005 Nov;46(11):1881-8. J Nucl Med. 2005. PMID: 16269603 Free article.

10

Internalisation and retention of EGF-dextran associated radioactivity in transfected Chinese hamster ovary cells expressing the human EGF-receptor.

Olsson P, Collins VP, Liu L, Gedda L, Liljegren A, Carlsson J. Olsson P, et al. Among authors: carlsson j. Int J Oncol. 2002 May;20(5):1057-63. Int J Oncol. 2002. PMID: 11956604

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

924 results

Search Page

Filters